News for Bio-Path Holdings, Inc. (BPTH)

Roth Capital has revised its price target for Bio-Path Holdings (BPTH), lowering it from $9 to $2, while maintaining a Buy rating. This update follows the compa

Highlights Promise of DNAbilize® Platform to Produce New Drug Candidates and Potential Licensing Opportunities HOUSTON, June 03, 2025 (GLOBE NEWSWIRE) --

Bio-Path Holdings (BPTH) will host a corporate update conference call on May 29, 2025, at 8:30 a.m. ET. The company focuses on developing targeted nucle

Bio-Path Holdings (BPTH) recently announced the successful completion of a third milestone in their preclinical studies for BP1001-A, highlighting its potential

Data suggest BP1001-A prevents fatty acid-induced insulin resistance in cells HOUSTON, May 01, 2025 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (BPTH), a b

Reports Continued Progress Across Both Obesity and Oncology Franchises HOUSTON, March 28, 2025 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (BPTH), a biotec

Recent Pre-Clinical Studies Showed BP1001-A Attenuated Fatty Acid-Induced Insulin Resistance and Restored Insulin Sensitivity in Muscle Progenitor and Skeletal

**media[569345]**

U.S. stocks traded mixed this morning, with the Dow Jones index falling around 100 points on Tuesday. Following the market opening Tuesday, the Dow traded down...

On December 31, 2024, ARMISTICE CAPITAL, LLC (Trades, Portfolio) executed a noteworthy transaction by acquiring 613,798 shares of Bio-Path Holdings Inc at a pri

First Solid Tumor Patient Treated with Second, Higher Dose in Phase 1/1b BP1001-A Clinical Trial Experienced Tumor Reduction and Continued Stable Disease Repor

Study Progresses to Fourth Higher 90 mg/m2 Dose Cohort Compelling Patient Response Highlighted by Stable Disease and Significant Reduction in Blast Count After

**media[511559]**

Israel-based software business My Size, Inc. (MYSZ) is up over 372 percent in Friday's pre-market trading. The following are some of the other stocks making big moves in Friday's pre-market trading.

U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.04%

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 100 points on Thursday. The Dow traded up 0.55% to 42,557.62 whil...

U.S. stocks traded higher midway through trading, with the S&P 500 gaining around 0.4% on Thursday. The Dow traded up 0.39% to 42,493.51 while the NASDAQ rose ...

U.S. stocks traded higher this morning, with the Dow Jones index gaining around 200 points on Thursday. Following the market opening Thursday, the Dow traded u...

Israel-based PainReform Ltd. (PRFX), a clinical stage biopharmaceutical company is up over 175 percent in Thursday's pre-market trading. The following are some of the other stocks making big moves in Thursday's pre-market trading.